Provided by Tiger Fintech (Singapore) Pte. Ltd.

IntraLinks

13.01
0.0000
Volume:- -
Turnover:- -
Market Cap:754.84M
PE:-37.17
High:13.01
Open:13.01
Low:13.01
Close:13.01
Loading ...

Coya Therapeutics, Inc. Announces Expansion of Exclusive Worldwide Licensing Agreement with ARScience Biotherapeutics, Inc. for Development and Commercialization of COYA 301, Coya’s Low-Dose Interleukin 2 (IL-2) Product Candidate

Business Wire
·
15 Feb 2023

IL man has to prove he’s alive after credit card stopped working

KMOV4
·
15 Feb 2023

Fitch Upgrades Mercy Health Corporation's (IL & WI) IDR to 'A' from ...

Fitch Ratings
·
15 Feb 2023

Blair William & Co. IL sells 15,634 Dynatrace, Inc. shares (NYSE:DT)

Best Stocks
·
14 Feb 2023

Blair William & Co. IL Acquires 94 Shares of Valero Energy Co ...

Defense World
·
13 Feb 2023

Roberts Glore & Co. Inc. IL Purchases 67806 Shares of Alphabet Inc ...

MarketBeat
·
13 Feb 2023

Table: DAE-IL Corp. FY Consolidated Net KRW7.41B Vs KRW29.49B

Dow Jones
·
13 Feb 2023

Blair William & Co. IL acquires 45,490 Exelixis, Inc. shares ...

Best Stocks
·
13 Feb 2023

Blair William & Co. IL Raises Position in Carvana Co. (NYSE:CVNA)

MarketBeat
·
12 Feb 2023

Blair William & Co. IL Grows Holdings in The PNC Financial ...

MarketBeat
·
12 Feb 2023

Top 100 biotech venture investors; Bristol Myers' IL-12 breakup ...

Endpoints News
·
12 Feb 2023

Blair William & Co. IL Has $12.49 Million Stake in Sealed Air Co ...

MarketBeat
·
10 Feb 2023

Blair William & Co. IL acquires 1,474 Lowe's Companies, Inc. shares ...

Best Stocks
·
10 Feb 2023

Blair William & Co. IL Increases Its Investment in Ritchie Bros ...

Best Stocks
·
10 Feb 2023

AstraZeneca deals another blow to IL-12, dumping therapy to follow ...

FierceBiotech
·
09 Feb 2023

City of Alton, IL and Ameresco Move Forward on 5MW Solar Project

Business Wire
·
09 Feb 2023

Blair William & Co. IL Raises Position in Ryan Specialty Holdings ...

MarketBeat
·
08 Feb 2023

Dragonfly chief: Bristol Myers shouldn't blame IL-12's clinical ...

Endpoints News
·
07 Feb 2023

Bristol-Myers Squibb to Return Development Rights for IL -12 Investigational Immunotherapy Program to Dragonfly

Marketscreener.com
·
07 Feb 2023

Big Pharma Bristol-Myers Returns $475M IL-12 Oncology Asset To Dragonfly

Benzinga
·
07 Feb 2023